Levobunolol Ophthalmic

Major

Levobunolol Ophthalmic Albuterol ProAir Reduced efficacy of albuterol Details Levobunolol Ophthalmic Ceritinib Zykadia Increased risk of bradycardia Details Levobunolol Ophthalmic Clonidine Duraclon An increased risk of worsen sinus node dysfunction and atrioventricular node conduction, an increased risk of bradycardia and AV b... Details Levobunolol Ophthalmic Crizotinib Xalkori An increased risk of bradycardia Details Levobunolol Ophthalmic Darunavir Increased beta blocker exposure and an increased risk of beta blocker-related adverse effects Details Levobunolol Ophthalmic Diltiazem Cardizem An increased risk of hypotension, bradycardia and slow AV conduction Details Levobunolol Ophthalmic Dronedarone Multaq Increased exposure to some beta blockers and increased incidence of bradycardia Details Levobunolol Ophthalmic Epinephrine Antagonized cardio stimulating, bronchodilation effects of EPINEPHrine, increased risk of hypertension, increased risk of bradycar... Details Levobunolol Ophthalmic Fenoldopam Exaggeration of hypotensive response Details Levobunolol Ophthalmic Fingolimod Gilenya Severe bradycardia or heart block Details Levobunolol Ophthalmic Formoterol Perforomist Reduced efficacy of formoterol or reduced efficacy of beta-adrenergic blocker Details Levobunolol Ophthalmic Indacaterol Decreased efficacy of indacaterol Details Levobunolol Ophthalmic Insulin Afrezza Increased or reduced blood glucose lowering effect of insulin and reduced symptoms of hypoglycemia Details Levobunolol Ophthalmic Insulin Icodec-Abae Awiqli An increased risk of hypoglycemia, which may sometimes be followed by hyperglycemia and an increased risk of blunted recognition o... Details Levobunolol Ophthalmic Iobenguane I 131 Azedra Inaccurate dosimetry calculations or reduced efficacy Details Levobunolol Ophthalmic Iohexol Lower threshold for contrast reactions, increased risk of more severe contrast reaction, reduced efficacy when treating hypersensi... Details Levobunolol Ophthalmic Lacosamide Motpoly An increased risk of AV block, bradycardia, and ventricular tachyarrhythmia Details Levobunolol Ophthalmic Landiolol An increased risk of myocardial contractility depression and increase the risk of bradycardia or heart block Details Levobunolol Ophthalmic Levalbuterol Xopenex Reduced efficacy of levalbuterol Details Levobunolol Ophthalmic Melatonin An increased risk of suppression of endogenous melatonin levels Details Levobunolol Ophthalmic Methylergonovine Methergine An increased risk of enhanced vasoconstrictive Details Levobunolol Ophthalmic Olodaterol Striverdi Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Levobunolol Ophthalmic Oxymetazoline Afrin Increased blood pressure Details Levobunolol Ophthalmic Phenelzine Nardil An increased risk of exaggerated hypotensive effect and an increased risk of bradycardia Details Levobunolol Ophthalmic Ponesimod Ponvory An increased risk of severe bradycardia and heart block Details Levobunolol Ophthalmic Rivastigmine Exelon Additive bradycardic effects Details Levobunolol Ophthalmic Salmeterol Serevent Reduced efficacy of salmeterol Details Levobunolol Ophthalmic Terbutaline Brethine® Reduced efficacy of terbutaline Details Levobunolol Ophthalmic Verapamil Calan An increased risk of hypotension, bradycardia and slow AV conduction Details Levobunolol Ophthalmic Vilanterol Decreased efficacy of vilanterol Details